Journal article

Determinants of treatment response in first-episode psychosis: an F-18-DOPA PET study

Sameer Jauhar, Mattia Veronese, Matthew M Nour, Maria Rogdaki, Pamela Hathway, Federico E Turkheimer, James Stone, Alice Egerton, Philip McGuire, Shitij Kapur, Oliver D Howes

Molecular Psychiatry | NATURE PUBLISHING GROUP | Published : 2019

Grants

Awarded by Wellcome Trust


Awarded by Medical Research Council


Awarded by Maudsley Charity grant


Funding Acknowledgements

We would like to thank the patients who took part in the study, and staff from Early Intervention Services, specifically Dr Rahaman, Dr Montgomery and Dr Morrison. Professor O.D.H. has received speaker bureau honoraria and charitable reseach funding from AstraZeneca, BMS, Eli Lilly, Jannsen-Cilag, and Roche. Dr O.D.H. work has been funded by the Medical Research Council, UK, and Wellcome Trust. Professor S.K. has received grant support from AstraZeneca and GlaxoSmithKline and has served as consultant and/or speaker for AstraZeneca, Bioline, BMS-Otsuka, Eli Lilly, Janssen (J&J), Lundbeck, NeuroSearch, Pfizer, Roche, Servier, and Solvay Wyeth. Dr Howes is funded by Medical Research Council grant MC-A656-5QD30, Maudsley Charity grant 666, support from the US Brain & Behavior Research Foundation, and Wellcome Trust grant 094849/Z/10/Z to Dr Howes and the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King's College London. Dr Veronese is funded by the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King's College London. Dr Jauhar is is funded by the National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King's College London, and a JMAS SIM Fellowship from the Royal College of Physicians, Edinburgh.